Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bajetta

Showing results (131-140 of 212) with videos related to

Pageof 22
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
An I.T.M.O. group study on second-line treatment in advanced epithelial ovarian cancer: an attempt to identify clinical and biological factors determining prognosisA Di Leo, E Bajetta, L Biganzoli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 8, 2007
Capecitabine plus oxaliplatin and irinotecan regimen every other week: a phase I/II study in first-line treatment of metastatic colorectal cancerE Bajetta, L Celio, E Ferrario, et al.
Tumori|May 7, 2002
Capecitabine: indications and future perspectives in the treatment of metastatic colorectal and breast cancerA Cassata, G Procoplo, M Alù, et al.
Breast Cancer Research and Treatment|January 1, 1994
Effect of two-4-hydroxyandrostenedione doses on serum insulin-like growth factor I levels in advanced breast cancerL Ferrari, N Zilembo, E Bajetta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
Biological activity of anastrozole in postmenopausal patients with advanced breast cancer: effects on estrogens and bone metabolismE Bajetta, A Martinetti, N Zilembo, et al.
International Journal of Radiation Oncology, Biology, Physics|September 16, 1999
Chemoradiotherapy as preoperative treatment in locally advanced unresectable pancreatic cancer patients: results of a feasibility studyE Bajetta, M Di Bartolomeo, S C Stani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1993
Prognostic factors in patients affected by hepatocellular carcinoma treated with systemic chemotherapy: the experience of the National Cancer Institute of MilanM Colleoni, E Bajetta, P Nelli, et al.
Cancer|July 21, 1998
5-Fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumorsE Bajetta, L Rimassa, C Carnaghi, et al.
Cancer|August 27, 1999
Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumorsE Bajetta, L Ferrari, A Martinetti, et al.
Oncology|May 1, 1994
Goserelin in premenopausal advanced breast cancer: clinical and endocrine evaluation of responsive patientsE Bajetta, N Zilembo, R Buzzoni, et al.
Pageof 22

Showing results (131-140 of 212) with videos related to

Sort By:
Pageof 22
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
An I.T.M.O. group study on second-line treatment in advanced epithelial ovarian cancer: an attempt to identify clinical and biological factors determining prognosisA Di Leo, E Bajetta, L Biganzoli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 8, 2007
Capecitabine plus oxaliplatin and irinotecan regimen every other week: a phase I/II study in first-line treatment of metastatic colorectal cancerE Bajetta, L Celio, E Ferrario, et al.
Tumori|May 7, 2002
Capecitabine: indications and future perspectives in the treatment of metastatic colorectal and breast cancerA Cassata, G Procoplo, M Alù, et al.
Breast Cancer Research and Treatment|January 1, 1994
Effect of two-4-hydroxyandrostenedione doses on serum insulin-like growth factor I levels in advanced breast cancerL Ferrari, N Zilembo, E Bajetta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
Biological activity of anastrozole in postmenopausal patients with advanced breast cancer: effects on estrogens and bone metabolismE Bajetta, A Martinetti, N Zilembo, et al.
International Journal of Radiation Oncology, Biology, Physics|September 16, 1999
Chemoradiotherapy as preoperative treatment in locally advanced unresectable pancreatic cancer patients: results of a feasibility studyE Bajetta, M Di Bartolomeo, S C Stani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1993
Prognostic factors in patients affected by hepatocellular carcinoma treated with systemic chemotherapy: the experience of the National Cancer Institute of MilanM Colleoni, E Bajetta, P Nelli, et al.
Cancer|July 21, 1998
5-Fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumorsE Bajetta, L Rimassa, C Carnaghi, et al.
Cancer|August 27, 1999
Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumorsE Bajetta, L Ferrari, A Martinetti, et al.
Oncology|May 1, 1994
Goserelin in premenopausal advanced breast cancer: clinical and endocrine evaluation of responsive patientsE Bajetta, N Zilembo, R Buzzoni, et al.
Pageof 22